MedPath

Prophylactic TBR on Phantom Limb Pain

Not Applicable
Not yet recruiting
Conditions
Phantom Limb Pain After Amputation
Registration Number
NCT06956508
Lead Sponsor
OrthoCarolina Research Institute, Inc.
Brief Summary

This prospective study seeks to evaluate the effectiveness of prophylactic Targeted Brain Rehabilitation (TBR) in preventing or reducing Phantom Limb Pain (PLP).

Detailed Description

Phantom limb pain (PLP) affects 60-80% of amputees, including both upper and lower extremity amputees, leading to increased anxiety, depression, and reduced quality of life. With the total prevalence of major limb amputees in the United States projected to reach 3 million by 2050 and approximately 185,000 new cases annually, there is a pressing need for effective interventions to prevent and manage PLP.

Current pharmacologic treatments offer limited relief and can lead to adverse outcomes, particularly with long-term opioid use. Non-pharmacologic alternatives, such as mirror therapy, lack strong evidence supporting their efficacy and, to our knowledge, have not been evaluated in the perioperative period.

Virtual reality (VR) has emerged as a promising tool for mitigating various aspects of the phantom limb experience in major limb amputees. Previous research has shown that VR treatments can significantly reduce PLP, with many studies reporting a drop in numeric pain scores after VR use, and can be cost-effective. However, current literature on VR therapy for PLP has never evaluated its use in the immediate post operative period.

Initiating VR therapy immediately post-amputation may help in preventing maladaptive cortical reorganization, which is believed to be a key factor in the development of PLP. Following amputation, the sensory-motor cortex undergoes rapid rewiring as the brain attempts to compensate for the loss of sensory input from the amputated limb. This reorganization can lead to the formation of aberrant neural connections, contributing to the perception of phantom limb sensations and pain. By providing a virtual representation of the missing limb and facilitating its movement, VR therapy may be able to help maintain the integrity of the sensory-motor cortex, potentially preventing or reducing the development of PLP.

Our research team hypothesizes that prophylactic use of Targeted Brain Rehabilitation (TBR), a VR-based therapy system, in the perioperative period following major amputation can prevent or reduce the development of PLP and decrease the usage of opioids in this population. Furthermore, introducing VR therapy in the immediate post-operative period could help mitigate the psychological distress associated with amputation. By addressing both the physical and psychological aspects of amputation from the outset, prophylactic VR therapy has the potential to significantly improve the quality of life for amputees and reduce the long-term burden of PLP. Establishing the efficacy of prophylactic TBR in the perioperative period could revolutionize the standard of care for amputees, potentially reducing the incidence and severity of PLP and its associated psychological and quality of life impacts. This study will lay the groundwork for future multi-center, randomized controlled trials to validate the effectiveness of prophylactic TBR and establish it as a potential standard of care for amputees.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 13+ year old patients undergoing major amputation with Dr. Gaston and Dr. Loeffler in the 12-24 months after the start of this study.
  • Ability to read and comprehend English.
  • Willing to use VR daily while in the inpatient setting following major amputation.
Exclusion Criteria
  • Patients under 12 years of age, and patients aged 13-17 without a legal guardian to give consent.
  • Have used TBR extensively in the past for prior/unrelated amputation.
  • Active uncontrolled mental illness
  • Active neurological disease or cognitive impairment that would interfere with VR therapy or survey completion.
  • Non-English speaking (surveys will only be provided in English)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Short Form McGill Pain Questionnaire (SF-MPQ)Through study completion, an average of 1 year

Assesses quality/intensity of their pain experience using descriptive words. Consists of 15 descriptors rated on an intensity scale. Includes visual analog scale (VAS). Administered to both groups. One composite score.

Secondary Outcome Measures
NameTimeMethod
Numeric Pain Rating Scale (NPRS)Through study completion, an average of 1 year

Self-report pain on a scale of 0-10, where 0 means no pain and 10 means the worst pain imaginable

Brief Pain Inventory (BPI) - Short FormThrough study completion, an average of 1 year

9-item questionnaire to assess pain severity and interference (two composite scores)

Phantom Limb Experience SurveyThrough study completion, an average of 1 year

Assesses presence, onset, location, character, intensity, triggers, and treatment of phantom limb sensations and phantom limb pain. Includes questions on phantom limb posture, movement, size changes, and telescoping.

Phantom Limb AssessmentThrough study completion, an average of 1 year

Assesses frequency, duration, and intensity of phantom limb pain compared to previous session. Assesses phantom limb posturing and control of phantom limb. Assesses duration of treatment effects in intervention group.

Simulator Sickness QuestionnaireThrough study completion, an average of 1 year

Assesses symptoms of simulator sickness including nausea, oculomotor problems, and disorientation. Only administered to intervention group.

System Usability Scale (SUS)Through study completion, an average of 1 year

Assesses subjective usability and satisfaction with the VR system.

Overall VR experience and feedback surveyThrough study completion, an average of 1 year

Supplemental questions to SUS

EuroQol five-dimensional health questionnaire (EQ-5D-5L)Through study completion, an average of 1 year

Assesses generic health status, quality of life, anxiety/depression

Patient Health Questionnaire-9 (PHQ-9)Through study completion, an average of 1 year

Objectifies and assesses degree of depression severity via questionnaire.

Daily Pain Log - Additional QuestionsThrough study completion, an average of 1 year

Assesses frequency and duration of phantom limb pain each day.

Trial Locations

Locations (1)

OrthoCarolina Research Institute

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath